BioCentury
ARTICLE | Company News

ZyStor, Symbiontics metabolic deal

December 16, 2004 8:00 AM UTC

Symbiontics (St. Louis, Mo.) granted ZyStor (Milwaukee, Wis.) exclusive rights to its glycosylation independent lysosomal technology that is designed to improve the delivery of therapeutics for lysoso...